Actively Recruiting
Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospective Case Series
Led by Reset Medical and Wellness Center · Updated on 2026-03-20
75
Participants Needed
1
Research Sites
66 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study prospectively evaluates the effects of Integrative Bilateral Cervical Sympathetic Block (BCSB) on trauma-related symptoms in Special Operations Veterans, comparing outcomes in those receiving BCSB alone versus BCSB combined with structured integrative therapy. Using standardized FDA-approved dosing, validated symptom measures, and strict safety criteria, the study aims to determine whether this dual-level autonomic intervention improves PTSD-related and TBI-related symptoms, and whether pairing the procedure with therapy enhances durability and overall clinical benefit.
CONDITIONS
Official Title
Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospective Case Series
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Diagnosed with PTSD with a PCL Score of 33 or greater at baseline screening
- Willing and able to provide informed consent and complete study procedures
- Fluent in English
- Special Operations Forces Veteran
You will not qualify if you...
- Received any cervical sympathetic block (unilateral or bilateral) within the past 6 months
- Currently enrolled in another interventional clinical trial or receiving experimental treatment for PTSD, TBI, or autonomic dysfunction
- Experiencing acute psychiatric crisis requiring inpatient care, active suicidal or homicidal intent, untreated mania, psychosis, or severe dissociation
- Known medical conditions that contraindicate BCSB such as anatomical abnormalities, bleeding disorders, allergy to local anesthetics, pregnancy, or other comorbidities as judged by physician
- Inability to read, speak, or understand English sufficiently to complete consent and assessments
- PCL-5 Score below 33 at screening indicating minimal PTSD symptoms
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Reset Medical and Wellness Center
Strongsville, Ohio, United States, 44136
Actively Recruiting
Research Team
M
Michael Louwers, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here